Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of p38-MAPK (unknown origin)
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Inhibition of P38betaMAPK (unknown origin)
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
Inhibition of JNK3 (unknown origin)
Assay data:13 Active, 1 Activity ≤ 1 nM, 13 Activity ≤ 1 µM, 13 Tested
Inhibition of p38alpha (unknown origin)
Assay data:14 Active, 12 Activity ≤ 1 µM, 15 Tested
Inhibition of SAPK2a/p38 (unknown origin)
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of p38 MAPK (unknown origin)
Inhibition of MAPK (unknown origin)
LanthaScreen Eu Kinase Binding Assay from US Patent US10865384: "2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis"
Assay data:20 Active, 16 Activity ≤ 1 µM, 20 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Kinase Assay from US Patent US10865384: "2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis"
Assay data:42 Active, 38 Activity ≤ 1 µM, 44 Tested
P38 MAP Kinase Assay from Article 10.1021/cc1000488: "One-pot synthesis of 4,6-diaryl-2-oxo(imino)-1,2-dihydropyridine-3-carbonitrile; a New Scaffold for p38alpha MAP kinase inhibition."
Assay data:10 Active, 4 Activity ≤ 1 µM, 10 Tested
Enzyme Inhibition Assay from Article 10.1016/j.bmcl.2003.12.023: "Benzimidazolone p38 inhibitors."
Assay data:40 Active, 38 Activity ≤ 1 µM, 49 Tested
Enzyme Inhibition Scintillation Proximity Assay from Article 10.1038/nsb949: "Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity."
Assay data:6 Active, 3 Activity ≤ 1 nM, 6 Activity ≤ 1 µM, 6 Tested
Kinase Inhibition Assay from Article 10.1016/s0969-2126(98)00113-0: "Structural basis of inhibitor selectivity in MAP kinases."
Assay data:4 Active, 4 Activity ≤ 1 µM, 5 Tested
Thermal Denaturation Assay from Article 10.1021/jm030121k: "Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)."
Assay data:18 Active, 8 Activity ≤ 1 nM, 18 Activity ≤ 1 µM, 18 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
p38alpha Kinase Enzyme Assay from Article 10.1021/jm049575n: "Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation."
Assay data:7 Active, 6 Activity ≤ 1 µM, 19 Tested
Inhibition of p38 alpha (unknown origin)
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
Inhibition of human STK36
Inhibition of human RIPK2
Inhibition of human NLK
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on